Following the sale of 6,000,000 units in a prior offering, Basel Medical Group Ltd received exercise notices for all associated Common Warrants. The company issued 6,000,000 new Ordinary Shares to satisfy these exercises using the zero cash exercise option. No proceeds were raised from this transaction. As of October 29, 2026, total ordinary shares outstanding increased to 13,582,111. Basel Medical Group Ltd operates in the healthcare sector.
